PPAR-α mediates the hypolipidemic function of fibrates in the treatment of hypertriglyceridemia and hypoalphalipoproteinemia [22], being the main regulator of intra- and extracellular lipid metabolism. Here, PPARA is linked to hypertriglyceridemia.